FDA Warns Baxter Over Dialysis Systems
Baxter failed to report several serious incidents with its HomeChoice peritoneal dialysis systems within the required 30 days, the FDA said in a June 3 letter that was publicized Tuesday. Some of the complaints showed the devices may have contributed to serious injuries, the FDA said.
The FDA's warning stems from an inspection of Baxter's McGaw Park, Ill.,...
To view the full article, register now.